Biora Therapeutics Inc (NASDAQ:BIOR) shares are trading lower by 45% to 74 cents during Tuesday's session after the company announced that it will be delisted from Nasdaq following a decision by the Nasdaq Hearings Panel due to non-compliance with the market value requirements under Nasdaq Listing Rule 5550(b).

Biora Therapeutics says trading of the company's securities on Nasdaq will cease at the opening of business on December 11, with Nasdaq filing a Form 25 to formalize the delisting after all appeal periods expire.

Biora anticipates its shares will transition to trading on the OTC Pink Current Information tier under the ticker symbol "BIOR" immediately following the Nasdaq suspension.

Read Also: Why Interactive Strength Stock Is Trading Higher

According to data from Benzinga Pro, BIOR has a 52-week high of $19.90 and a 52-week low of $0.70.